Skip to main content
Top
Published in: Clinical Rheumatology 10/2013

01-10-2013 | Original Article

Test–retest reliability of the Disease Activity Score 28 CRP (DAS28-CRP), the Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI) in rheumatoid arthritis when based on patient self-assessment of tender and swollen joints

Authors: Cecilie Heegaard, Lene Dreyer, Charlotte Egsmose, Ole Rintek Madsen

Published in: Clinical Rheumatology | Issue 10/2013

Login to get access

Abstract

Composite disease activity scores are frequently used in daily practice as tools for treatment decisions in patients with rheumatoid arthritis (RA). If reliable, patient-reported disease activity may be time saving in the busy clinic. The objective was to examine the test–retest reliability of the Disease Activity Score 28 CRP (DAS28-CRP) with four variables (4v) and three variables (3v), the Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI) when based on patient self-assessment of tender and swollen joints and to examine the agreement between these scores and physician-derived scores. Thirty out-clinic RA patients with stable disease were included. A joint count was performed two times 1 week apart by the patient and by an experienced physician. Test–retest reliability was expressed as the least significant difference (LSD), as the LSD in percent of the mean score (%LSD) and as intra-individual coefficients of variation (CVi). Mean scores based on physician vs. patient joint counts (visit 1) were: DAS28-CRP(4v) 3.5 ± 1.0 vs. 3.6 ± 1.1 (not significant (NS)), DAS28-CRP(3v) 3.4 ± 0.9 vs. 3.5 ± 0.9 (NS), SDAI 14.2 ± 9.4 vs.14.1 ± 9.4 (NS) and CDAI 13.4 ± 9.3 vs. 13.3 ± 9.4 (NS). The LSDs (%LSD) for duplicate assessments of patient-derived scores (visit 2 vs. 1) were: DAS28-CRP(4v) 0.8 (23.2), DAS28-CRP(3v) 0.9 (25.2), SDAI 8.3 (59.9) and CDAI 8.4 (63.8). Similar LSDs were found for differences between duplicate assessments of physician-derived scores and for differences between physician and patient-derived scores. CVis for SDAI and CDAI were significantly higher than for DAS28-CRP(4v) and DAS28-CRP(3v) (p < 0.005). Patient- and physician-derived scores agreed closely on group level. On the individual level, the LSDs between patient- and physician-derived scores were considerable but corresponded to both patient and physician intra-observer LSDs. Thus, scores based on patient-performed joint counts may be an alternative to traditional physician-derived scores in patients with stable disease.
Literature
1.
go back to reference Felson DT, Anderson JJ, Boers M et al (1993) The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 36:729–740PubMedCrossRef Felson DT, Anderson JJ, Boers M et al (1993) The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 36:729–740PubMedCrossRef
2.
go back to reference Prevoo ML, Van'tHof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef Prevoo ML, Van'tHof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef
3.
go back to reference Fransen J, Welksing PMJ, de Keijzer RMH et al (2003) Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis 62:151CrossRef Fransen J, Welksing PMJ, de Keijzer RMH et al (2003) Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis 62:151CrossRef
5.
go back to reference Madsen OR (2011) Is DAS28-CRP with three and four variables interchangeable in individual patients selected for biological treatment in daily clinical practice? Clin Rheumatol 30:1577–1582PubMedCrossRef Madsen OR (2011) Is DAS28-CRP with three and four variables interchangeable in individual patients selected for biological treatment in daily clinical practice? Clin Rheumatol 30:1577–1582PubMedCrossRef
6.
go back to reference Aletaha D, Smolen J (2005) The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23(Suppl 39):S100–S108PubMed Aletaha D, Smolen J (2005) The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23(Suppl 39):S100–S108PubMed
7.
go back to reference Osborne RH, Wilson T, Lorig KR et al (2007) Does self-management lead to sustainable health benefits in people with arthritis? A 2-year transition study of 452 Australians. J Rheumatol 34:1112–1117PubMed Osborne RH, Wilson T, Lorig KR et al (2007) Does self-management lead to sustainable health benefits in people with arthritis? A 2-year transition study of 452 Australians. J Rheumatol 34:1112–1117PubMed
8.
go back to reference Solomon M, Wagner SL, Goes J (2012) Effects of a Web-based intervention for adults with chronic conditions on patient activation: online randomized controlled trial. J Med Internet Res 14:e32PubMedCrossRef Solomon M, Wagner SL, Goes J (2012) Effects of a Web-based intervention for adults with chronic conditions on patient activation: online randomized controlled trial. J Med Internet Res 14:e32PubMedCrossRef
9.
go back to reference Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310PubMedCrossRef Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310PubMedCrossRef
10.
go back to reference Glüer CC, Blake G, Lu Y et al (1995) Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int 5:262–270PubMedCrossRef Glüer CC, Blake G, Lu Y et al (1995) Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int 5:262–270PubMedCrossRef
11.
go back to reference Madsen OR (1996) Trunk extensor and flexor strength measured by the Cybex 6000 dynamometer. Assessment of short-term and long-term reproducibility of several strength variables. Spine 21:2770–2776PubMedCrossRef Madsen OR (1996) Trunk extensor and flexor strength measured by the Cybex 6000 dynamometer. Assessment of short-term and long-term reproducibility of several strength variables. Spine 21:2770–2776PubMedCrossRef
12.
go back to reference Pease C, Pope JE, Truong D et al (2011) Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy. Semin Arthritis Rheum 41:81–89PubMedCrossRef Pease C, Pope JE, Truong D et al (2011) Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy. Semin Arthritis Rheum 41:81–89PubMedCrossRef
13.
go back to reference Orlewska E, Ancuta I, Anic B et al (2011) Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries. Med Sci Monit 17:SR1–SR13PubMedCrossRef Orlewska E, Ancuta I, Anic B et al (2011) Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries. Med Sci Monit 17:SR1–SR13PubMedCrossRef
14.
go back to reference Barton JL, Criswell LA, Kaiser R et al (2009) Systematic review and metaanalysis of patient self-report versus trained assessor joint counts in rheumatoid arthritis. J Rheumatol 36:2635–2641PubMedCrossRef Barton JL, Criswell LA, Kaiser R et al (2009) Systematic review and metaanalysis of patient self-report versus trained assessor joint counts in rheumatoid arthritis. J Rheumatol 36:2635–2641PubMedCrossRef
15.
go back to reference Radner H, Grisar J, Smolen JS et al (2012) Value of self-performed joint counts in rheumatoid arthritis patients near remission. Arthritis Res Ther 14:R61PubMedCrossRef Radner H, Grisar J, Smolen JS et al (2012) Value of self-performed joint counts in rheumatoid arthritis patients near remission. Arthritis Res Ther 14:R61PubMedCrossRef
16.
go back to reference van Gestel AM, Prevoo ML, van’t Hof MA et al (1996) Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 39:34–40PubMedCrossRef van Gestel AM, Prevoo ML, van’t Hof MA et al (1996) Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 39:34–40PubMedCrossRef
17.
go back to reference Uhlig T, Kvien TK, Pincus T (2009) Test–retest reliability of disease activity core set measures and indices in rheumatoid arthritis. Ann Rheum Dis 68:972–975PubMedCrossRef Uhlig T, Kvien TK, Pincus T (2009) Test–retest reliability of disease activity core set measures and indices in rheumatoid arthritis. Ann Rheum Dis 68:972–975PubMedCrossRef
18.
go back to reference Aletaha D, Martinez-Avila J, Kvien TK et al (2012) Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index. Ann Rheum Dis 71:1190–1196PubMedCrossRef Aletaha D, Martinez-Avila J, Kvien TK et al (2012) Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index. Ann Rheum Dis 71:1190–1196PubMedCrossRef
20.
go back to reference Magid E, Petersen PH, Christensen M (1992) A note on the theory of reference changes. Scand J Clin Lab Invest 52(Suppl 208):95–101CrossRef Magid E, Petersen PH, Christensen M (1992) A note on the theory of reference changes. Scand J Clin Lab Invest 52(Suppl 208):95–101CrossRef
21.
go back to reference Nilas L, Hassager C, Christiansen C (1988) Long-term precision of dual energy X-ray absorptiometry in the lumbar spine in clinical settings. Bone Miner 3:305–315PubMed Nilas L, Hassager C, Christiansen C (1988) Long-term precision of dual energy X-ray absorptiometry in the lumbar spine in clinical settings. Bone Miner 3:305–315PubMed
22.
go back to reference Walsh CA, Mullan RH, Minnock PB et al (2008) Consistency in assessing the disease activity score-28 in routine clinical practice. Ann Rheum Dis 67:135–136PubMedCrossRef Walsh CA, Mullan RH, Minnock PB et al (2008) Consistency in assessing the disease activity score-28 in routine clinical practice. Ann Rheum Dis 67:135–136PubMedCrossRef
23.
Metadata
Title
Test–retest reliability of the Disease Activity Score 28 CRP (DAS28-CRP), the Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI) in rheumatoid arthritis when based on patient self-assessment of tender and swollen joints
Authors
Cecilie Heegaard
Lene Dreyer
Charlotte Egsmose
Ole Rintek Madsen
Publication date
01-10-2013
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 10/2013
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2300-9

Other articles of this Issue 10/2013

Clinical Rheumatology 10/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.